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In this lecture I will discuss some of the relevant history of
cGMP-selective and cGMP-regulated phosphodiesterases.
Emphasis will be put largely on those experiments carried
out in our own laboratories over the last 40 years. Short
vignettes or anecdotes on the discoveries of the "cGMP-
stimulated" (PDE2s) and "cGMP-inhibited" (PDE3s)
phosphodiesterases as well as on the original cloning of
PDEs 5,6, 9, and 11 will be mentioned. I will then spend
a bit more time discussing a recent series of experiments
on the opposing roles of PDE2s and PDE3s in endothelial
barrier function. These experiments provide data to sug-
gest that both of these PDEs can subserve one or more
pools of cGMP that can functionally regulate endothelial
permeability, but in opposite directions depending on the
cGMP concentration. Finally, I will describe a series of
experiments that strongly suggest treatment of whole ani-
mals with selective PDE5 antagonists may provide effec-
tive functional improvement in the cardiac dysfunction
that occurs in muscular dystrophy. These studies utilize
two different models of muscular dystrophy in the mouse.
When given chronically in the drinking water, sildenafil
appears not only to stop the decline in cardiac function
that occurs with age, but also may reverse existing dys-
function after it has developed, at least as assessed by
echocardiography.
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